Keyword: Pfizer

The AMA has announced a new partnership to support gun research as a public health issue, plus other healthcare headlines from around the web.

A conversation with George W. Bush and a session on end-of-life care with Atul Gawande highlight the this year's AHIP Institute and Expo keynotes.

Former CVS Health executive Daniel Best and current HHS Administrator Brett Giroir, M.D., have been appointed to two new senior advisory roles at the agency.

A shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives that may lead to dosage mistakes.

Some physicians and other industry experts are growing uneasy about the role of marketing in leveraging parental fears to sell the MenB vaccine.

A new consortium of payers, providers and manufacturers at Duke University has highlighted data as one of the key barriers to value-based agreements.

To control spending on prescription drugs, hospital leaders are deploying tactics like better staff training and tighter formularies.

To fight the high cost of prescription drugs, an upstate New York insurer is giving big pharma a dose of its own medicine.

Despite the popular perception that greedy drugmakers are responsible for rising healthcare costs, some experts say that hospitals are the true culprits and pharma is getting a bad rap.

From Kaiser Health News: With federal investigators bearing down on his committee, Tom Price showed little restraint in investing in health companies.